CDK5 and liver cancer: Thirdly, the signaling pathway regulated by lncRNAs, such as lncRNA PVT1/miR-214-3p/GPX4, are expected to become potential targets for the treatment of liver cancer.[29] However, there are still no effective therapies by targeting ATG9B-4/ARNTL/CDK5.